Ms. Porkizhi Arjunan is a Ph.D. candidate at the Centre for Stem Cell Research, Vellore, Tamil Nadu. Her doctoral research focuses on targeted non-viral vector-based gene therapy for hemophilia A and B (HA and HB) disorders, and her goal is to reduce bleeding in hemophilia patients while avoiding additional complications. During her Ph.D., she has also worked on other projects, such as making innovative nano-lithocholic lipidoids—a potential class of therapeutics for treating psoriasis. Furthermore, using novel liposomes, she assisted in the production of SARS-CoV-2 pseudovirions during the Covid-19 outbreak and contributed to the finding that Omicron infection increases IgG binding to spike protein of predecessor variants. Her research has been published in peer-reviewed international journals and has been presented at several national and international conferences.
Ms. Arjunan holds a bachelor’s and a master’s degree in biotechnology from Pondicherry University, Puducherry and Bharathidasan University, Tamil Nadu respectively. She also holds a diploma in computer applications and training. In addition to her work, she has a strong interest in social work, and likes traveling and meeting people from different cultures.
As a Fulbright-Nehru Doctoral Research fellow, Ms. Arjunan is exploring the potential reach of the proposed “Development of Lipid Nanoparticle guided chemically modified Factor FVIII mRNA/NE-DNA Nucleic Acid Therapeutics for Hemophilia A.”